Bay­er starts work on $43M+ ex­pan­sion of OTC man­u­fac­tur­ing site in Penn­syl­va­nia

Ger­man phar­ma gi­ant Bay­er will be look­ing to make a sig­nif­i­cant in­vest­ment in­to one of its US plants that pro­duces over-the-counter drugs.

Bay­er an­nounced that it will spend $43.6 mil­lion to ex­pand its fa­cil­i­ty in My­er­stown, PA, a small town east of Har­ris­burg. Bay­er plans to in­crease the site by 70,000 square feet and will have room for the in­stal­la­tion of eight pack­ag­ing lines and an area to in­stall rooftop so­lar pan­els. The project is ex­pect­ed to be com­plet­ed by 2025 and will add around 50 to 75 jobs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER